Rheum for Everyone, Episode 24 (video)| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Osteoarthritis and Bone Disorders

Methotrexate May Mitigate Inflammatory Bone Disease Note Experts at the ACR/ARHP Winter Rheumatology Symposium

Kimberly Retzlaff  |  April 2, 2014

By regulating molecules key to osteoclast/osteoblast processes, methotrexate may reduce bone destruction in inflammatory arthritis, osteolysis, especially in combination with adenosine

Rheumatology Drug Updates

Michele B. Kaufman, PharmD, BCGP  |  March 1, 2014

Information on new approvals and medication safety that rheumatologists need to know

Research Reveals Clues Into Inflammatory Process of Crystal Arthropathies Note Experts at the 2013 ACR/ARHP Annual Meeting

Susan Bernstein  |  March 1, 2014

New studies clarify the roles of monosodium urate crystals in gout, calcium pyrophosphate crystals in osteoarthritis, and identify more effective potential therapies for patients

What Role Does Fascia Play in Rheumatic Diseases?

Helene M. Langevin, MD  |  March 1, 2014

Recent research explores possible connections between abnormalities in fasciae and painful musculoskeletal conditions such as chronic back pain, osteoarthritis, and rheumatoid arthritis, as well as scleroderma

Nonsurgical Treatments Can Relieve Pain, Improve Hand Function in Thumb Carpometacarpal Joint Osteoarthritis

Norman P. Gustafson, MS, OTR/L, CHT, Bruce M. Jacobs, BS, OTR/L, and Nancy A. Baker, ScD, MPH, OTR/L  |  March 1, 2014

OA can affect hand anatomy and kinematics, but splinting, exercise techniques, and physical agent modalities can help

Pharmacy-based Arthritis Screening Debuts in Canada

Kurt Ullman  |  February 1, 2014

Co-sponsored program between the Ministry of Health and pharmacy chain tasks pharmacists with screening people for knee osteoarthritis

Coding Corner Question: February

Staff  |  February 1, 2014

Test your coding knowledge for an evaluation and management visit by a patient with rheumatoid arthritis and osteoporosis who is starting a tumor necrosis factor inhibitor

Rheumatologists On The Move

Caitlin Cromley  |  January 1, 2014

Awards, appointments, and announcements in the world of rheumatology

Coding Corner Question: January

Staff  |  January 1, 2014

Test your coding knowledge for a dual-energy X-ray absorptiometry scan for a Medicare patient with postmenopausal osteoporosis

Telomere Length Provides Insights into Cartilage Aging and Repair

Lara C. Pullen, PhD  |  October 8, 2013

Chondrocyte telomere length might play a role in the natural aging of cartilage, as well as the development and progression of OA.  (posted Oct. 8, 2013)

  • « Previous Page
  • 1
  • …
  • 35
  • 36
  • 37
  • 38
  • 39
  • …
  • 46
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences